PRESENTATION

FY2020 — Results presentation

FY2020PDF · 84 pages12.2 MB
1
1
for the year ended 30 June 2020

-- 1 of 84 --

2
Core new business
to R19 173m
Normalised
operating profit
to R6 069m
Headline earnings
to R296m	to R8 409m
Normalised operating
profit before reserving for
future COVID-19 impacts
Normalised headline
earnings
to R3 747m

-- 2 of 84 --

3
The Group focused on capital strength and liquidity
Operating performance was resilient with operating profit up 9%, new business up 5% and actuarial
dynamics in line with expectation
Interest rate movements had a R4.8bn pre-tax effect on headline earnings, but minimal impact on
cashflows, solvency or liquidity and excluded from normalised earnings
A COVID-19 reserve of R3.4bn was created to cater for all future COVID-19 impacts. 13% of the life
claims provision has been used with the balance of the provision sufficient for a potential second wave
Growth engine remains robust with pleasing results from Established, remarkable profit growth from
Emerging and an investment of R2.2bn into New businesses, which are seeing considerable traction
Core new business
to R19 173m
Normalised operating
profit
to R6 069m
Headline earnings
to R296m	to R8 409m
Normalised operating profit
before reserving for future
COVID-19 impacts
Normalised headline
earnings
to R3 747m

-- 3 of 84 --

4
Our strategic response to the pandemic
Keep every staff member safe
Maintain connectivity
Live out our values
Ensure business continuity
Ensure products are fit-for-purpose
Keep people healthy and active
Ensure operating profit strong with appropriate and conservative reserve for COVID-19
Minimise the impact on liquidity and solvency
Protect the capital plan
Maintain financial strength and resilience
Support the healthcare system
Strengthen the healthcare system
Play an outsized role
COVID Alert
SA app
DISCOVERY
talks
COVID-19
information hub
Support our
country
Protect our
people
Protect and
support our clients
“My pick so far is
Discovery, it had an
American astronaut talk
about isolation, al-Qaeda
hostage on resilience,
Jessica Ennis-Hill gave a
live aerobics class”
Vitality at Home
COVID-19
concessions
Behavioural
shared value

-- 4 of 84 --

5
Globally two waves are emerging but SA has passed the peak
SA’s stringent lockdown was successful
in flattening and delaying the peak
• Early lockdown reduced infection
rate
• Allowing more time for
development of treatment insights
• Resulting in greater capacity in
healthcare system
South
Africa

-- 5 of 84 --

6
28%
20% 19% 15% 15%
8%
8% 6%
5% 4%
7%
4% 5%
3% 2%
High care ward ICU ward Ventilation
SA is benefiting from advancements in treatment
-
5
10
15
20
25
30
35
40
45
50
Rest of
SA
KZN
Gauteng
EC
WC
New York health system overwhelmed at
50 new daily infections per 100 000 lives
-60%
reduction in average length of
stay of COVID-19 admissions
SA has passed the peak,
decreasing daily new infections Advancements in treatment insights improved efficiency and reduced severity
Average LOS
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
11-May 11-Jun 11-Jul 11-Aug
-25%
reduction in ICU deaths
-51%
reduction in cases requiring
high acuity intervention
Proportion of recovered cases
SA
Total
Expected mortality in early stages was 0.38%, now reduced to 0.28%-0.32%

-- 6 of 84 --

7
The impact of lockdown on behaviour is evident
0%
20%
40%
60%
80%
100%
120%
140%
160%
180%
07-Jan	
14-Jan	
21-Jan	
28-Jan	
04-Feb	
11-Feb	
18-Feb	
25-Feb	
04-Mar	
11-Mar	
18-Mar	
25-Mar	
01-Apr	
08-Apr	
15-Apr	
22-Apr	
29-Apr	
06-May	
13-May	
20-May	
27-May	
03-Jun	
10-Jun	
17-Jun	
24-Jun	
01-Jul
08-Jul
15-Jul
22-Jul
29-Jul
05-Aug	
12-Aug	
19-Aug	
26-Aug
Lockdown
level 5
Lockdown
level 3
Lockdown
level 4
Lockdown
level 2 Bank spend*
*Indexed to average January 2020
Healthy Food
Physical activity
12% reduction in level 5,
now 11% above prior levels
43% reduction in level 5,
now 11% below prior levels
16% reduction in level 5,
now 7% below prior levels
83% reduction in level 5,
now 30% below prior levels
Driving
2019

-- 7 of 84 --

8
Our strategic focus areas
Financial and
social impact
Foundation
Businesses

-- 8 of 84 --

9
3 190 +5% 3 190 +5%
4 029 +25% -1 979 2 971 -8% -3 634
830 -14% -181 830 -14%
246 +59% 246 +59%
SA Composite1 8 302 +11% 7 244 -3%
1 543 +104% -713 830 +9%
297 -49% -569 -272 -147% -1 193
UK Composite1 1 840 +38% 558 -58%
308 +91% 308 +91%
182 +72% 182 +72%
New businesses -2 223 +70% -2 223 +70%
Total 8 409 +9% -3 442 6 069 -22% -4 827
Rm
SA Composite
UK Composite
Partner
Composite
1 Excluding New initiatives
2 Net of discretionary margins
(-2 3402)
(-1 0582)
(02)
Operating profit before
reserving for future
COVID-19 impacts
Reserve
for future
COVID-19
Interest
rate effect
Operating
profit

-- 9 of 84 --

10
Operating performance was resilient with operating profit up 9%,
new business up 5% and actuarial dynamics in line with expectation

-- 10 of 84 --

11
3 190 +5%
4 029 +25%
830 -14%
246 +59%
SA Composite1 8 302 +11%
1 543 +104%
297 -49%
UK Composite1 1 840 +38%
308 +91%
182 +72%
New businesses -2 223 +70%
Total 8 409 +9%
Rm
SA Composite
UK Composite
Partner
Composite
1 Excluding New initiatives
Operating profit before
reserving for future
COVID-19 impacts
Resilient operating variances and cash generation. Robust capital
and liquidity
Strong asset gatherer. Earnings curtailed by once-off factors
Operational excellence and strong retention. Earnings inflated by
delayed claims due to the NHS co-opting private hospitals
Executed on its turnaround plan. Set up for future recovery
Strong quality of business. Scaling the Shared-Value Model
Resilient revenue with operating leverage. Capitalise on enhanced
relevance and leading global position
Remarkable growth. Continued investment for long-term
opportunities
Bank migrations complete, fully deposit-funded. Rapid learnings to
improve user experiences and value proposition
Strong performance and supporting society. Driving efficiencies

-- 11 of 84 --

12
New business Rm 12 months
to 30 Jun 2020
12 months
to 30 Jun 2019 % change
6 101 6 695 -9%
2 286 2 312 -1%
2 667 2 604 +2%
1 238 1 346 -8%
1 257 1 291 -3%
1 089 1 041 +5%
1 134 922 +23%
3 575 2 518 +42%
New businesses 825 386 +114%
-5%
+29%
ESTABLISHED BUSINESSES
EMERGING BUSINESS
NEW
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
– vs 2019 level

-- 12 of 84 --

13
Resilient operating performance, actuarial dynamics within expectation
Lapses	
– vs expected
Claims	
– vs expected
Life claims for Life Cover, Capital Disability and Severe Illness only
VitalityLife lapse experience excludes once off process change in June
Paid up
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
Withdrawals
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
 0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June
0%
50%
100%
150%
Jan
Feb
Mar
Apr
May
June

-- 13 of 84 --

14
A COVID-19 reserve of R3.4bn was created: 13% of the life claims provision
has been used with the balance of the provision sufficient for a potential
second wave

-- 14 of 84 --

15
Jul-20	
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20	
Jan-21	
Feb-21	
Mar-21	
Apr-21	
May-21	
Jun-21
Cumulative actual
Cumulative provision
The COVID-19 claims reserve is appropriate and sufficient for a potential
second wave
Modelled 3 scenarios R-factors Actual deaths vs projected Actual progression
-
20,000
40,000
60,000
80,000
100,000
120,000
Feb-20	
Mar-20	
Apr-20	
May-20	
May-20	
Jun-20	
Jul-20	
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20
Low Medium High
46%
population
infected H2 20
23%
population
infected H2 20
6%
population
infected H2 20
-
10,000
20,000
30,000
40,000
50,000
60,000
70,000
Feb-20	
Mar-20	
Apr-20	
May-20	
May-20	
Jun-20	
Jul-20	
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20
Low Medium High
8.7%
population
infected 20
6.6%
population
infected 20
6.1%
population
infected 20
of total life claims
provision used
Illustrative if second wave
Sufficient
if second
wave
Cumulative deaths
Cumulative deaths
South Africa
Discovery
March June	May August
1
2
3
March June	May August
1
2
3
-
20
40
60
80
100
120
140
160
Feb-20	
Mar-20	
Apr-20	
May-20	
Jun-20	
Jul-20
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20
Low Medium High Actual
-
100
200
300
400
500
Feb-20	
Mar-20	
Apr-20	
May-20	
Jun-20	
Jul-20	
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20
Low Medium High Actual
Indicative
Cumulative Discovery Life deaths
Cumulative Vitality Life deaths
of expected to
date

-- 15 of 84 --

16
Authorisations in VH are starting to rebound, delays in seeking treatment
could increase costs
0%
20%
40%
60%
80%
100%
120%
Monthly authorisations per 1 000 lives
CARDIAC ONCOLOGY
PSYCHIATRY OVERALL
Overall authorisations are still below pre-COVID-19 levels,
August 82% of normal
Delays in seeking
oncology
treatment could
prove costly as
cancers are likely
to be more
advanced
Delays in treatment could manifest in increased severity costs and result in increased uncertainty in the reserving process
0%
20%
40%
60%
80%
100%
120%
140%
Jan-20	
Feb-20	
Mar-20	
Apr-20	
May-20
Jun-20	
Jul-20
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20	
Jan-21	
Feb-21	
Mar-21	
Apr-21	
May-21
Jun-21	
Jul-21
Aug-21
Claims spend expected compared to authorisations received
Claims shaping within the business plan Overall auths witnessed
Expect above normal utilisation of services until policyholders
and hospitals catch-up on treatments which have been
delayed
Assume:
• 90% non-elective missed claims recur
• 20% elective procedures missed will not come back
• Cases delayed suffer additional costs due to COVID testing, additional
overnight stays, or increased severity
MUSCULOSKELETAL

-- 16 of 84 --

17
Interest rate movements had a R4.8bn pre-tax effect on headline
earnings, but minimal impact on cashflows, solvency or liquidity and
excluded from normalised earnings
0%
5%
10%
15%
Jun-06	
Jul-07	
Aug-08	
Sep-09	
Oct-10	
Nov-11	
Dec-12	
Jan-14	
Feb-15	
Mar-16	
Apr-17	
May-18	
Jun-19
Real Nominal -4%
-2%
0%
2%
4%
6%
Jan-06
Jan-08
Jan-10
Jan-12
Jan-14
Jan-16
Jan-18
Jan-20
Real Nominal

-- 17 of 84 --

18
-
50
100
150
-200bps -150bps -50bps Base +50bps +180bps +250bps
10 year available cashflow 5 year available cashflow
NRR SCR Cover
-
50
100
150
Base -20bps -40bps -60bps -80bps -100bps
SCR Cover NRR NRR & Hedge Return
110
90
Continued volatility in interest rates negatively affected headline earnings
Record levels of interest rates Impact on Discovery Life and VitalityLife IFRS impact
Lowest levels of real and nominal rates in history
25-year UK Real and Nominal Gilt Yields
Highest levels of nominal rates in recent history
Hedge protected against further decreases
-80
-60
-40
-20
-
20
40
60
2019/10/12	
2019/12/01	
2020/01/20	
2020/03/10	
2020/04/29	
2020/06/18	
2020/08/07
Millions
Liability Change Hedge TotalInclForwardRate
Total impact
Total impact
25-year Real and Nominal Yields
Reinvestment risk
Valuation risk
SCR and cashflow stress to nominal interest rates, indexed to Base
0%
5%
10%
15%
Jun-06	
Jun-07	
Jun-08	
Jun-09	
Jun-10	
Jun-11	
Jun-12	
Jun-13	
Jun-14	
Jun-15	
Jun-16	
Jun-17	
Jun-18	
Jun-19	
Jun-20
Real Nominal
-4%
-2%
0%
2%
4%
6%
Jan-06	
Jan-07	
Jan-08	
Jan-09	
Jan-10	
Jan-11	
Jan-12	
Jan-13	
Jan-14	
Jan-15	
Jan-16	
Jan-17	
Jan-18	
Jan-19	
Jan-20
Real Nominal
SCR and cashflow stress to nominal interest rates, indexed to Base
110
90

-- 18 of 84 --

19
Growth engine remains robust with pleasing results from Established,
remarkable profit growth from Emerging and an investment of R2.2bn into
New businesses, which are seeing considerable traction

-- 19 of 84 --

20
The organic growth methodology
-13%
Invested in New
26%
14%
FY18 – FY23
3%
FY21 – FY25
R7.6bn
-R2.2bn
3 190
4 029
830
1 543
297
246
308
182
VitalityInvest
Discovery Business Insurance
Umbrella Funds
Vitality1
Rm
*
*Ignoring investment in future New initiatives
~5 years
~5 years
ESTABLISHED
EMERGING
NEW
Investment of
10% of profit
*
Normalised operating profit before
reserving for future COVID-19 impacts Normalised operating profit
3 190
2 971
830
830
-272
+15%
+74%
R9.9bn
R736m

-- 20 of 84 --

21
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Substantial and planned spend on New businesses; seeing considerable
traction
Majority on Bank
53%
11%
Other
Breakdown of FY20
operating loss
Monthly new
business run rate
VitalityInvest DBI	Umbrella Funds
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Monthly new
business run rate
Committed assets
Vitality1
New over next 21 months
July 2020 March 2022
BRAZIL SPAIN ITALY	SAUDI ARABIA
21 months pipeline
3X
POWERED
BY
POLAND
CZECH
REPUBLIC
PORTUGAL MEXICO INDIA
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun

-- 21 of 84 --

22
The Group focused on capital strength and liquidity

-- 22 of 84 --

23
Cash management supports the growth methodology
Cash generated from in-force
1 Movement in shareholder free cash
Cash
generated
Cash
used	Funding
Reinsurers
Cash generated from
in-force business
R15.4bn
Cash used net of funding
Net cash flow
Debt
Tax, dividends and
finance costs
New business
R3.9bn
R8.0bn
Net cash flow1
R3.8bn
New businesses
R2.6bn

-- 23 of 84 --

24
Debt is reducing
Group is well capitalised and highly liquid
Strongly capitalised
Rm June 19
Cover
June 20
Cover
1.6x 1.8x
1.7x 1.8x
1.4x 1.7x
1.5x 2.0x
1.6x
Sufficient liquidity at the
centre
Highly liquid across the
Group2
28%
DHMS solvency 32.7%
1 Capital Adequacy Ratio
2 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
3 SA cash + undrawn committed facilities
1
SA Liquidity3 , R millions	FLR
-
2,000
4,000
6,000
8,000
10,000
FY18 FY19 FY20
R millions
Jun-17
Dec-17
Jun-18
Dec-18
Jun-19
Dec-19
Jun-20
Jun-21
 -
500
1,000
1,500
2,000
FY18 FY19 FY20 FY21
Liquid excess assets above regulatory
capital requirements

-- 24 of 84 --

25
Opening EV VNB Unwind RDR Non-economic
experience
variances
Non-economic
methodology
and assumption
changes
Operational EV Economic* Forex Other - finance
costs and Group
initiatives
Change in
capital and
dividends
Closing EV
Return on Embedded Value
5% excluding forex and
economic changes
Operational EV Economic and other
76 398
71 217 70 834
*Economic experience variances and methodology & assumption changes

-- 25 of 84 --

26
Reconciliation to normalised headline earnings
Rm
12 months ended
Jun 2020
12 months ended
Jun 2019 % change
Profit from operations before reserving for future COVID impacts 8 409 7 747 +9%
Reserve for future COVID-19 impacts, net of discretionary margins (2 340)
Profit from operations 6 069 7 747 -22%
Economic assumptions adjustments (4 830)
Dilution gains from equity accounted investments 3 808
Gain on previously held interest in Discovery Card business 0 761
Finance charges excl. 1DP finance lease (1 218) (1 036)
Foreign exchange gains 578
Other (79) (148)
Profit before tax 523 8 132 -94%
Tax (347) (1 518)
Profit attributable to preference shareholders (81) (81)
Loss attributable to non-controlling interest 2
Profit attributable to ordinary shareholders 97 6 533 -99%
Dilution gains from equity-accounted investments, net of tax (3) (666)
Gain on previously held interests in Discovery Card business - (761)
Loss on de-recognition of assets net of tax 149 -
Other 53 41
Headline earnings 296 5 147 -94%
Economic assumption adjustments net of interest rate derivative and net of tax 3 584 –
Other (133) (112)
Normalised headline earnings 3 747 5 035 -26%

-- 26 of 84 --

27
The strategic foundation
PURPOSE VALUES PEOPLE
BRAND MODEL CAPABILITIES
Make people
healthier and
enhance and
protect their lives
Great people
Liberating the best in people
Intellectual leadership
Drive, tenacity and urgency
Innovation and optimism
Business astuteness and prudence
Dazzle clients
Integrity, honesty and fairness
Best person for
every role

-- 27 of 84 --

28
NATURE
OF RISK TECHNOLOGY
SOCIAL
RESPONSIBILITY
“We want revolutionary actuaries”
Tesla launching insurance company
- premiums based on data collected
by cars’ internal sensors
Global trends have the power to transform insurance markets and have
been accelerated by COVID-19
The nature of risk is behavioural
The nature of COVID-19
risk is behaviourial
Accelerated rush online
Social and environmental movements amplifying corporate responsibility
• The rise of digital
• Ways of work
• Ecommerce
• Telemedicine
• Contactless
The nature of behaviour
on mortality
Banking
Motor
Life
Health
“Digitally enabled, customer
centric and drive engagement”
“Deep understanding of risk and
how to manage it”
“Producing profitable solutions to the problems of people and planet, not profiting
from producing problems for people or planet” Colin Mayer
“It’s time to tie bank profits to
customers financial health”

-- 28 of 84 --

29
Impact of risk factors on COVID-19 mortality
COVID-19 risk is also behavioural
Exercise	No exercise
1.0
1.6
2.0
2.5
0.9
1.0
1.2
45 year old
unengaged male
65 year old male
No chronic
conditions Hypertension
Hypertension
and
diabetes
No chronic
conditions Hypertension
Hypertension
and
diabetes

-- 29 of 84 --

30
Make people healthier
and enhance and
protect their lives
Life insurance
Health insurance
Short-term insurance
Long-term savings
Banking

-- 30 of 84 --

31
Vitality platform underpinning all initiatives
INCENTIVE LAYER
TECHNOLOGY AND ANALYTICS LAYER
INCENTIVE
MEMBER
BEHAVIORAL LAYER
△ BEHAVIOR
INCENTIVE
DATA LAYER
△ RISK
△ BEHAVIOR
PRICING LAYER
VALUE
△ RISK
TECHNOLOGY AND ANALYTICS LAYER
DATA LAYER
BEHAVIORAL LAYER
INCENTIVE LAYER
PRICING LAYER
INCENTIVE
MEMBER
△ BEHAVIOR
INCENTIVE
△ RISK
△ BEHAVIOR
VALUE
△ RISK
=
x
x
x
VALUE
MEMBER
SERVICE
PRODUCT
ACTIVE REWARDS 2020 for Seniors
HEALTH BEHAVIORS CONTENT DEVELOPMENT
Pre-
commitment
Nudge
theory
Loss
Aversion
BEHAVIORAL DESIGN GLOBAL INTEGRATED PARTNERS
BEHAVIORS -> RISK FACTORS -> CHRONIC CONDITIONS -> MORTALITY RESEARCH
COLLABORATIONS
FRAMEWORK AND CO-DEVELOPERS CLIENTS
1 KOREA
GERMANY
FRANCE
AUSTRIA
ARGENTINA GROUP BENEFITS
None Blue
Bronze
Silver
Gold
DYNAMIC PRICING WEDGE FUNDING

-- 31 of 84 --

32
Shared-Value dynamics manifest across all industries
LIFE HEALTH MOTOR	LONG-TERM SAVINGS
Claims
Lapses
No VD Blue Bronze Silver Gold Diamond
No VD Blue Bronze Silver Gold Diamond	SA UK Market A
Blue Bronze Silver Gold
SA UK
Blue Bronze Silver Gold
SA UK
Blue Bronze Silver Gold
SA UK Market
A
Market
B
Market
C
Market
D
Blue Bronze Silver Gold
None Blue Bronze Silver Gold Diamond
None Blue Bronze Silver Gold Diamond

-- 32 of 84 --

33
Perfect composite model, #1 in every industry, and laboratory for shared value in financial services. A
successful entry into banking
The best insurer in the UK, making use of a composite Shared-Value Model
Vitality is the world’s largest and most sophisticated behavioural platform linked to financial services, with
disciplined execution
Ping An Health delivers on its plan to become the leading health insurer in China with over 50m clients
The four strategic strands

-- 33 of 84 --

34
UK COMPOSITE MODEL PARTNER COMPOSITE
MODEL
SA COMPOSITE MODEL

-- 34 of 84 --

35
1 2 3 4 5 6
The composite delivers superior outcomes and there is still a significant
integration opportunity
Composite delivers lower lapses and greater up-selling
1 2 3 4
Lapse rate by # of policies Premium size by # of policies
54 17 13 7 6
81 68 38 20 19
59 57 55 29 19
60 55 25 22 15
40% of Life clients
have < 2 products
Average product take-
up <1.6
Common behaviour architecture
with stacked incentives
Still a significant composite opportunity
-88% 1.5x
Correlations between risk
behaviours
Holistic client view
Efficient distribution
80% of retail clients only have 1 product	80% of employer groups only have 1 product
Small (10-100) Medium (100-400) Large (400+)
6,200 corporates 1,200 corporates 500 corporates
Group Risk
Retirement Funds
Healthy Company	90
20 2

-- 35 of 84 --

36
J A S O N D J F M A M J J A S
Accounts Retail deposits Credit facilities	Clients
J A S O N D J F M A M J J A S	J A S O N D J F M A M J J A S	J A S O N D J F M A M J J A S
2019 2020 2019 2020 2019 2020 2019 2020
Utilised
R3.7bn
As at 14 September

-- 36 of 84 --

37
Costs continue to be tightly managed in the Bank’s first year of operation
R4 535m
Actual
R4 552m
Expected
Total spend since inception to date
FY20 IFRS Result
R1 171m
Actual
R1 179m
Expected
43
348
1,179
29
353
1,171
Infrastructure Build Run
Expected Actual
FY20 spend (Rm)

-- 37 of 84 --

38
Strategic focus areas
Prudent, deposit-led growth
strategy, while ensuring the
quality of the loan book
Seamless migration
of >223 000 clients
Rapid learning and
continuous improvement

-- 38 of 84 --

39
Successful and seamless completion of migration of FNB JV loan Book
0
100
200
300
400
500
600
Jun-19	
Jul-19
Aug-19	
Sep-19	
Oct-19	
Nov-19	
Dec-19	
Jan-20	
Feb-20	
Mar-20	
Apr-20	
May-20
Jun-20	
Jul-20
Aug-20	
Sep-20
Thousands
Discovery Bank account growth
Card-by-card New-to-Bank Upgrade from Bin Still in Bin
Apr-20 May-20 Jun-20 Jul-20
Bulk BIN Migrations
Accounts migrated over from
FNB to Discovery Bank
18k
61k
27k
63k

-- 39 of 84 --

40
Deposit growth Funding	Capital resilience Deposit distribution
Deposits exceeded the loan book, resulting in significant liquidity
0
1
2
3
4
J A S O N D J F M A M J J A S
Retail Deposits Advances
Funding surplus/ (shortfall) Rbn
Current +20pp1
-30%
0%
Percentage change in retail deposits
Credit limit utilisation
Current
R3.5bn
1:percentage points
55%
14% 11% 5%3% 2%1% 1% 1% 1% 1% 7%
R’000
3% 6%
12%
3%
64%
13%
Blue
Bronze
Silver
Gold
Diamond
VM not setup
Vitality Money status
Amount
Wholesale and
retail deposits
Credit
utilisation
Surplus
Rbn, as at 7 September
(Excluding capital)
6.25
(3.56)
2.69

-- 40 of 84 --

41
Credit quality Credit distribution Arrears	Financial affluence
The quality of the loan book is excellent and the Bank is maintaining a
prudent credit growth strategy
0%
25%
50%
75%
100%
Discovery Bank Market
Group 1 Group 2 Group 3
Group 4 Group 5 Group 6
0
100
200
300
400
500
600
700
800
Client Credit Score
Exceptionally
Low Risk
Low Risk
Medium Risk
High Risk
Very High
Risk
35%
15%
19%
11%
6% 4% 3% 2% 1% 1% 1% 3%
R’000	Group 1 = Most affluent (2019)	Average credit score (2016 – 2019)
lower than market
0%
2%
4%
6%
8%
10%
12%
14%
16%
J F M A M J J
Discovery Bank Market

-- 41 of 84 --

42
Learnings from Vitality Money
Shared-Value fundamentals Value received by clients
Blue Bronze Silver Gold Diamond
Blue Bronze Silver Gold Diamond
Blue Bronze Silver Gold Diamond
Arrears rate
Deposit levels
Spend
HealthyFood miles rewarded
Active Rewards rings closed
airtime and electricity transactions
discounted

-- 42 of 84 --

43
New design of Vitality Money
Retirement
Debt
Management Property	Insurance	Savings
Determine Status and interest rates
Engage and earn Discovery Miles
Use your Discovery Miles
Points to Miles Healthy Living Spend anywhere
Exercise Drive
Blue Bronze Silver Gold Diamond
Spend Monetize Convert Donate
Up to
75% Up to R15
per
Refined proposition
1
2
3
A new face of Shared-Value Banking
Bank
accounts
and
balances
The
“armadillo”

-- 43 of 84 --

44
Refined user experience with behavioural nudges
Accounts, Behaviours, Status and Interest rates
Immediately understand your status and your financial behaviours and scores and the impact on your interest rates
Landing page Status and where to improve Nudges and their impact
Earning Discovery Miles
Three simple ways: Points to Miles, Spend at partners; Spend
anywhere
Exercise Points to Miles Partner Spend to Miles

-- 44 of 84 --

45
New business
Rm
Lapses Membership Normalised operating profit
Rm
to R3 190m
2016 2017 2018 2019 2020
lives under administration
5.0%
4.5%
YTD Jun-19 YTD Jun-20
to R6 101m
2016 2017 2018 2019 2020
1993	
1995	
1997	
1999	
2001	
2003	
2005	
2007	
2009	
2011	
2013	
2015	
2017	
2019
DHMS Restricted Schemes

-- 45 of 84 --

46
DHMS growth
Rm
Closed scheme growth Retail product growth
Growth impacted by the contraction in employment
-
500
1,000
1,500
2,000
2,500
3,000
3,500
2016 2017 2018 2019 2020
Type I Type II
1997
1999
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
lives
closed schemes lives
Jan-18
Apr-18	
Jul-18
Oct-18	
Jan-19
Apr-19	
Jul-19
Oct-19	
Jan-20
Apr-20
Healthy Company
Gap cover
Primary Care
of DH revenue
year-on-year growth
Type I: new employer groups
Type II: new employees on existing groups

-- 46 of 84 --

47
Membership and growth Lapses and stability Security and surplus
1 Council of Medical Schemes Reductions in elective hospital admissions and general
healthcare utilisation emerging from COVID-19
unaudited solvency	credit rating	annualised lapse rate
Plan movements stability
Downgrade
No
movement
Upgrade
lives
market share1 as at Sep 2019
Growing market share in a contracting
open medical scheme environment
1993
1995
1997
1999
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
year-on-year change
2.8%
2.9%
94.3%
2002
2005
2008
2011
2014
2017
Aug-20
Year end reserve
position
2020 surplus
build-up
emerging from
COVID-19
Jan-20
Mar-20	
May-20
Jul-20
R26.6bn
R19.2bn

-- 47 of 84 --

48
-
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2-Mar	
9-Mar
16-Mar	
23-Mar	
30-Mar
6-Apr
13-Apr	
20-Apr	
27-Apr	
4-May
11-May	
18-May	
25-May
1-Jun	
8-Jun
15-Jun	
22-Jun	
29-Jun
6-Jul
13-Jul	
20-Jul	
27-Jul	
3-Aug
10-Aug	
17-Aug	
24-Aug	
31-Aug
Solvency build-up driven by the decline in non-COVID-19 healthcare
utilisation
Weekday hospital admissions index Weekday OH claims index
Total admissions
Medical admissions
Surgical admissions
LOCKDOWN
LEVEL 5
LOCKDOWN
LEVEL 4 LOCKDOWN LEVEL 3
Rolling 3 day average
OTC scripts issued
Physical GP consultations
Baseline
Rolling 3 day average
-
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2-Mar	
9-Mar
16-Mar	
23-Mar	
30-Mar
6-Apr
13-Apr	
20-Apr	
27-Apr	
4-May
11-May	
18-May	
25-May
1-Jun	
8-Jun
15-Jun	
22-Jun	
29-Jun
6-Jul
13-Jul	
20-Jul	
27-Jul	
3-Aug
10-Aug	
17-Aug	
24-Aug	
31-Aug
LOCKDOWN
LEVEL 5 LOCKDOWN
LEVEL 4 LOCKDOWN LEVEL 3
Baseline
LOCKDOWN
LEVEL 2
LOCKDOWN
LEVEL 2

-- 48 of 84 --

49
COVID-related admissions Hospital utilisation Hospital occupancy
Significant reduction in hospital utilisation with excess capacity even at
COVID-19 peak
COVID admissions peaked in July 2020 Overall hospital utilisation has reduced
by 27% YTD
Even at peak cases in July, hospital
occupancy levels were below 2019
0.6% 1.4%
6.3%
15.7%
8.5%
4.0%
Apr May Jun Jul Aug Sep
COVID as proportion of total admissions
Single hospital
-
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
Jan Feb Mar Apr May Jun Jul Aug
Total DH member hospital admissions
2020 COVID Admissions
2020 Non COVID admissions
2019 Admissions
0
200
400
600
800
1000
1200
0 200 400 600 800 1000 1200
2020 July volumes
2019 July volumes
Hospital occupancy levels (2019 vs.
2020)

-- 49 of 84 --

50
Convergence of data-driven insights to identify high-risk members and
care at home with remote monitoring has saved lives
Significant improvement in health
outcomes Significant reduction in mortality
Statistically proven to reduce admissions, lower case severity and improve mortality outcomes
through early detection of deterioration and proactive care
100%
73%
Baseline risk Pulse oximeter impact
Pulse oximeter impact on hospitalisation
-27%
100%
62%
Baseline risk Pulse oximeter impact
Pulse oximeter impact on mortality
-38%
at-risk clients identified
DH members received support
at home and remote monitoring

-- 50 of 84 --

51
Managing healthcare costs in 2021 and beyond
Principles informing
future management
of contribution rates:
Affordable increases
for 2021 and
equilibrium in 2022
Max
(pre-2021)
CPI + 0%
CPI + 2%
CPI + 4%
CPI + 6%
CPI + 8%
CPI + 10%
2016 2017 2018 2019 2020
DHMS
Top 6
open
schemes
Difference in contribution Increases:
DHMS vs Top 6 (2016-2020)
DHMS contribution increases are
consistently below industry levels
based on favourable tariff and
utilisation experience
Min
(pre-2021)
2015 2016 2017 2018 2019
Discovery Health average
inflation rates
Pricing for 2020 should reflect anticipated experience post-COVID-19
Correction of latent Non-COVID
demand projected for Q3 2021

-- 51 of 84 --

52
Strong cashflow, capital
and liquidity position	New business Normalised operating profit
to R2 286m
2016 2017 2018 2019 2020
to R2 971m
Solvency coverage
Cashflow generated
of liquidity
Operating Profit
pre-COVID-19
+25%
Net economic impact
Normalised operating profit
Operating profit before reserving for future
COVID-19 impact
2016 2017 2018 2019 2020
Resilient operating
variances
260
2010	
2011	
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020
Non-economic experience variances (Rm)
Positive non-economic
variances
Includes Discovery Invest

-- 52 of 84 --

53
146%
80%
>R10m
2019 2020
Positive operational experience variances; policy alterations impacted by
COVID-19
2020 operational
experience variances Improved mortality experience
Policy alterations
impacted by
COVID-19 relief
-241
-74 -82
16
-342
Jun 2017
Jun 2018
Jun 2019
Dec 2019
Jun 2020
Historic policy alterations variances
(Rm)
Claims experience AvE	Rm
115%
104%
93% 98%
2019 H1 H2 2020
Significant decrease
in large life claims
0.7% of
gross FY20
claims
Life claims by cause of death
(Rm)
Includes Discovery Invest
Lapses and surrenders
Mortality and morbidity	
Premium and fee income
Policy alterations
Other	
Total
Lapses and surrenders
Mortality and morbidity	
Premium and fee income
Policy alterations
Other	
Total
2019 2020

-- 53 of 84 --

54
Sufficient coverage for a
second wave
Cumulative Actual
Cumulative Provision
Actual progression
of Discovery Life
claims provision used
Sufficient if
second
wave
COVID-19 provision for excess
claims and lapses Actual COVID-19 claims experience
COVID-19 provision is appropriate and sufficient for a potential second
wave
Discovery Life COVID-19 Provision
split (Rm)
Claims:
957m
Lapses:
1 022m
Total COVID-19 Provisions
raised (Rm) 1 979
Release of Margin (Rm) (921)
Net COVID-19 Provision
impact (Rm) 1 058
-
20
40
60
80
100
120
140
Apr-20	
May-20
Jun-20	
Jul-20
Aug-20	
20 - 29	
30 - 39	
40 - 49	
50 - 59	
60 - 69	
70 - 79
80+
Vitality status, age-group claims shown as count per 1 000 lives
Gross monthly
claims (Rm)
Claims by
Vitality status (count)
Claims by age-
group (count)
None
Blue
Bronze
Silver
Gold/Diamond

-- 54 of 84 --

55
Premiums and Fees
Claims and PH reserves
Operational Costs
Cashflows from existing
NB Strain
Cashflow before FinRe
Net FinRe
Life and Invest Net cashflow
Jun-20
Strong cash emergence
R millions
Significantly improved capital position High levels of liquidity coverage
R millions
Includes once-off
R1.8bn gain from Asset-
Liability optimisation
182%
172%
159%
Jun20	Dec19	Jun19
125%
SCR
target
Driven by:
• Mass lapse RI treaty (Dec19)
• Higher interest rates at Jun20
• COVID provisions
• Balance sheet optimisation
R4.1bn
Assets available to
meet liquidity needs
c.R500m
FinRe available
from July 2020
Additional
Robust position evident in strong cashflow, capital coverage and liquidity
14 775
6 006
3 247 2 543

-- 55 of 84 --

56
2019 2020
Value of new business and embedded value impacted by COVID-19 and
economic assumption changes
Reduced value of new business and margin Analysis of embedded value: Life & Invest
to R31.8bn
421
923
2020	2019
Impacted by:
• Lower sales due to lockdown/restricted underwriting
• Economic assumption changes
• COVID-19 stress assumptions
Jun-19
New Business
Expected unwind incl New
Business
Experience Variances
Methodology and Assumption
Changes
COVID-19 Methodlogy and
Assumption Changes
Total before Economic Impact
Experience Variances
Methodology and Assumption
Changes
Components below the line
Jun-20
Economic
Non-economic
32.9bn
35.4bn
31.8bn
COVID-19
Pre-COVID-19 and
economic
VNB (Rm) Life: Annualised VNB margin (%) Life:
59%	25%
16% Expenses
Economic
COVID-19

-- 56 of 84 --

57
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
New business
Rm
Assets under administration
Rbn
Normalised operating profit
Rm
to R2 667m to R99bn to R830m
20
16
20
17
20
18
20
19
20
20
2016 2017 2018 2019 2020

-- 57 of 84 --

58
Compelling offering has led to good business outcomes
100
112
117
104
105
Q3
2018
Q4
2018
Q1
2019
Q2
2019
Q3
2019
Q4
2019
Q1
2020
Q2
2020
DSY AuM Industry AuM
Extending Shared-Value Model to offshore
Assets under management
growth Shared-Value metrics
invested in
preferred funds
reduced
withdrawals
lower
drawdowns
more ad-hoc
contributions
Market rate:
R 17.51
Currency enhancer
rate: R 16.29
Currency Enhancer
Buy in below the prevailing
exchange rate on qualifying
investment choices with the
Global Endowment
Global Portfolios
Risk profiled investment
Multi-fund active-passive
BlackRock & 3rd party asset
managers
Offshore
ZAR/USD
New
Foreign currency access at 7% below
market rate
Efficient and flexible international
investment

-- 58 of 84 --

59
to 94%*	to R246m
(excl. Commercial)
to R3 666m*
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
to R1 089m*
109
94
2016 2017 2018 2019 2020	2016 2017 2018 2019 2020
Gross written
premium New business Combined ratio
Normalised operating
profit Market share in GWP
2016 2017 2018 2019 2020
*Personal Lines only. Assumes 6% in GWP market
growth since 2018	
*Personal Lines only

-- 59 of 84 --

60
Insure’s performance through COVID-19 was remarkable
New business
Discovery Insure’s internal credit rating
system has produced a book with a
remarkably credit-worthy profile
Lapses Claims
New business has recovered and
is producing record sales levels
Expected the claims outcome due
to less exposure on the roads
June and July numbers may be understated as lapse experience to complete run-off due to Gap in Cover offering
127%
137%
124%
32%
68%
111% 107%
Jan Feb Mar Apr Mar Jun Jul
2019 level
100
111 106
64 62 66
77
Jan Feb Mar Apr May Jun Jul
100 103
87
59
66
39
86
Jan Feb Mar Apr May Jun Jul
Jan20
level Jan20
level

-- 60 of 84 --

61
UK COMPOSITE MODEL PARTNER COMPOSITE
MODEL
SA COMPOSITE MODEL

-- 61 of 84 --

62
New business Earned premiums Normalised operating profit	Lives covered
to £126.3m
GBP millions
to 1.3m lives
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
GBP millions
to £785.5m to £28.3m
GBP millions
2016 2017 2018 2019 2020
Operating profit
pre-COVID-19
+28%
Net economic impact
Normalised operating profit
Operating profit before reserving for future COVID-19
impact
2016 2017 2018 2019 2020

-- 62 of 84 --

63
UK businesses were resilient
500 000 home
workouts
101% increase in
benefit registrations
1.2m vouchers
issued
295 000 vouchers
issued
The businesses came together under the ‘One Vitality’ banner
Established group
governance structures
Consolidation of
functions
Composite member
experience
Group
VH VL VI Operations
Retentions
VH
Operations
Retentions
VL
Operations
Retentions
Group
+
Rapidly responded to COVID-19 by adapting benefits and rewards with Vitality at
Home

-- 63 of 84 --

64
to £62.7m
GBP millions
New business Lives covered Normalised operating profit
to 682k lives to £42.0m after allowance
for deferred claims
GBP millions
Earned premiums
GBP millions
to £496.7m
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
Allowance for deferred claims
Operating profit
Operating profit
pre-COVID-19
+89%

-- 64 of 84 --

65
Vitality Health’s response to deliver value in a dynamic and evolving
environment
Maintained provision of
critical care
Increased utilisation of
digital care
Fast-tracked launch of
Member Care Hub
Launched COVID-19
Cash Benefit
Pays £250 per night for
the first 8 nights, plus
£500 for each night in
hospital thereafter, up
to a maximum of £5 000
Vitality GP
appointments
GP Advice Line
members
accessing the hub
since March
Take-up of straight through
care requests following launch
0
1,000
2,000
3,000
4,000
0%
10%
20%
30%
40%
23 March	
30 March
6 April	
13 April	
20 April	
27 April	
4 May	
11 May	
18 May
Users
% users requesting care online	
Week beginning
% requesting care online
Care Hub Users
100% 99%
May to July
2019
May to July
2020
Cancer and other urgent
treatments continued
throughout lockdown
Mar-Jun20 vs Jul19-Feb20
Mar-Jun20 vs Jul19-Feb20
Adapted the Vitality
programme
Activity levels for members who
bought a device during lockdown
Up to 50% off selected devices
0
100
200
300
400
500
600
700
800
900
Base Early
lockdown
Current
MET
-minutes per week
 
+18%

-- 65 of 84 --

66
Cash
generated
from inforce
Write new
business
Invest in
project
initiatives
Net cash
generated
COVID allowance
Excellent retention and cash generation
Lapse rates sustained at low levels despite COVID-19 Strong cash generation
£58m
£122m
FY16 FY17 FY18 FY19 FY20
0%
20%
40%
60%
80%
100%
120%
Jan Feb Mar Apr May Jun Jul Aug
Lapse rate Lapse rate Actual vs Expected

-- 66 of 84 --

67
2016 2017 2018 2019 2020
to £63.6m
GBP millions
to 621k lives to -£13.8m
GBP millions
New business Lives covered Normalised operating profit	Earned premiums
to £288.8m
GBP millions
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
Operating profit
pre-COVID-19
-52%
Net economic impact
Normalised operating profit
Operating profit before reserving for future
COVID-19 impact

-- 67 of 84 --

68
Management actions to return VL to robust profitability are now in
place
Intervened against ‘high lapse’ brokers >100 firms’ 2 year agencies closed
Restructured franchise channel From 24 to 13 franchises, £3.4m saving
Consolidated ops and service at Group level Better consistent service and customer experience across
Vitality, 12% reduction in expenses through synergies
Enhanced retention capabilities Aims to eliminate experience variances
Strengthened actuarial bases and set up
COVID-19 provisions £29m impact
Entered into interest rate hedge
Protects against liquidity impact of further falls in
interest rates, allows participation in upside > 140bps,
and extends time to transition to longer term strategy
Deferred Part VII transfer Defers need to inject significant capital into VL for 3 years
Changed Group legal entity structure Capital benefit of >£125m
Adapted elements of actuarial methodology £23.5m reduction in SCR for 30 June 2020
Sourced liquidity funding in the UK £100m facility at 2% plus Libor
Area Impact	Management actions
OPERATIONS
CAPITAL
LIQUIDITY
Progress
1
2
3
4
5
8
9
10
7
6
Implemented Nov ’19 and May’20
Completed Apr ‘20
Completes Aug ‘20
Ongoing process, good traction
Effective from Jul ‘20
Implemented Feb ‘20
Implemented Sep ‘19, Jul ‘20
Confirmed Mar ‘20
Agreed Feb ‘20









Extended Jun ‘20	

-- 68 of 84 --

69
-20
-10
-
10
20
30
40
FY17 FY18 FY19 FY20 FY21
Millions
COVID-19 and interest rates impacted the period; expect profits to
revert
-80
-60
-40
-20
0
20
40
Plan Operating
profit pre
COVID-19
provision
COVID-19
provision
Normalised
operating
profit
Interest
rate impact
Operating
profit
£24m
-£61m
-£74m
-£29m
£15m
-£13m
Earnings impact
Expect operating profits to revert in
FY21
Indicative only, assumes no change in hedging
costs, no assumption changes and a range to
reflect potential experience variances
Uncertainty inherent in experience
Range
Substantial value if interest rates rise
-
200
400
600
800
1,000
1,200
1,400
1,600
1,800
Will increase discretionary margins
Hedge gives away upside for the first +/-
100bps after which there is upside in the form
of higher discretionary margins/P&L
Operating profit £945k
per 1bps
sensitivity for
IFRS reserve*
*Decreasing the higher interest rates go
Value impact (Rm)
Expected
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors

-- 69 of 84 --

70
PARTNER COMPOSITE
MODEL

-- 70 of 84 --

71
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020
Integrated API by
insurance partners Revenue2 Operating result
Insurance and franchise
partners membership
All numbers exclude new VG initiatives, i.e. AIA Health and Vitality1
1 From insurance partners
2016 2017 2018 2019 2020
Vitality USA Insurance Partners
2016 2017 2018 2019 2020
R15.8bn
USD1.0bn
R1.1bn
USD72.3m
R308m
USD19.6m
117%
CAGR
1.8m
2 Excludes services related to system implementation and other cost recoveries and rewards

-- 71 of 84 --

72
Execution of business strategy with partners has taken place rapidly
Exploit latent potential and scale
Rapid market expansion and
penetration
Pursue Shared-Value
adjacencies and partnerships
New business unit to expand global
health insurance initiatives
1
National
Champions
Powered By
Vitality
Franchise
Markets
Vitality Health
International
USA
PROGRAMS
PARTNERS
FITNESS GROCERS TRAVEL ACTIVE REWARDS	OTHER PLATFORM SUPPORT
ACTIVE REWARDS VITALITY DRIVE VITALITY FOR SENIORS CONDITION MANAGEMENT VITALITY DISTRIBUTION
PRODUCTS VITALITY FUNDS UPFRONT DISCOUNT COVER BOOST	PREMIUM FLEX
DATA*
CASHBACK
>20M VITALITY LIVES >4M ACTIVE DEVICES	>40M LIFE YEARS 24M WORKOUTS PER WEEK
*Data metrics across Discovery Group

-- 72 of 84 --

73
The case for Shared-Value Insurance is getting stronger
Risk is behavioural and traditional
models are exposed
Traditional insurance pricing models
PREMIUM
TIME
Flat market premium
Underwritten at
inception
Traditional models pool controllable
risk, which is inefficient, creates adverse
selection and selective lapsation
Shared-Value Insurance Model has no trade-offs
Vitality has codified behaviour and risk Dynamic pricing model
Sales & Selection
effect
Behavioural effect
Lapse
effect
65	
73	
81	
89	
97
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Age
0-0.1 0.1-0.2 0.2-0.3 0.3-0.4 0.4-0.5
0.5-0.6 0.6-0.7 0.7-0.8 0.8-0.9 0.9-1
Over 25 years in behavioural insurance,
and in collaboration with leading
academic institutions mortality has been
codified in over 1m curves for each age
based on different wellness and health
engagement behaviours
Lower cost of
insurance
7% -15%
Lower lapse rates by
health engagement
30% -70%
Increase in VNB
margin
10% -50%
Pricing of behaviour over the currency of
the insurance contract
Aligned to
recognition of
cohorts
IFRS 17
Improvement in
health outcomes
Up to
40%

-- 73 of 84 --

74
The Shared-Value Model creates true profitability
Market A
Base EV
from new
business
Increased
sales
Increased
repurchases
Improved
assumptions
Vitality
premium
Insurance
rewards
Vitality
rewards
Other Vitality
costs
c40%
incremental
EV from new
business
through
Vitality
Vitality
EV from new
business
• Internal value impact
analysis performed by
market
• Significant sales impact of
Vitality through both
incremental new business
and cross-purchases
• Costs include all
incremental costs
associated with programme
EV = Enterprise Value

-- 74 of 84 --

75
National Champions exhibit continued strong performance
IP VoNB = Integrated Premium Value of New Business
1. AIA Group 2020 Interim Results
2. % members that earned a point for physical activity in last 3 months (Q2 2020)
3. FY2019 customer survey
2015 2017 2019
Vitality IP VoNB
Since launch, Vitality
IP VoNB has nearly
doubled every year
Rapid membership growth
Engaging in some
form of exercise
because of Vitality3
84%More aware of
their health3	90%
+450K
members in
<2 years
%2 members active well above average amidst COVID-19
Market average
55%	28%
Higher repurchase rates for
highly engaged members1
+80%
Larger case sizes for
Vitality members1
2X Up to	Up to
AIA embedded Vitality in its global strategy, executing
the Shared-Value insurance model across Asia Pacific
‘All-in’
+91%
CAGR
Launch
+79%
Sept'18 Dec'18 Jun'19 Dec'19 Jun'20
Total Vitality linked sales (Germany)
2019 2020
very well received
Re-launched Vitality in existing markets in
quick succession, following a seamless
migration onto the V1 platform
Plans to roll-out Vitality across Europe in 2021/2022
+43%

-- 75 of 84 --

76
World-class technology solution
V 1 P L A T F O R M
to operate
to implement
to configure
V1 availability For 80% of points
to calculate
VDP availability Readings per day
Health assessments Goals achieved
Plethora of integrated
reward partners
Live markets
Internationally recognised
information security
management system
Strong, central product
development roadmap

-- 76 of 84 --

77
2016 2017 2018 2019 2020
New business1 Written premium1
PAH’s operating result
pre-tax
DSY’s operating result
after tax and management
expenses
to R14.3bn to R29.8bn to R1.9bn
(DSY’s share is R464m)
to R182m
1 100% of PAH
2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020

-- 77 of 84 --

78
Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20
Continued focus on quality business and investment in future capabilities
Headcount growth in technology skills	Quality business and operational excellence
Tech headcount split at head office
0%
20%
40%
60%
80%
100%
Jun-18 Dec-18 Jun-19 Dec-19 Jun-20
Tech Non-tech
Customer
reapplication rate
individual business
Combined
operating
ratio
% claims settled
within 1 day
Persistency
Service levels
Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20
Target
Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20
Target

-- 78 of 84 --

79
Large market opportunity but a changing competitive landscape
High growth expected from Chinese healthcare market Internet giants gaining traction within PHI
Medical expenditure
Source: World Health Organisation and Ernst and Young
Growth rate of world’s top 5
healthcare markets
Source: Data from the World Health Organisation as of end 2017
-5%
0%
5%
10%
15%
20%
China USA Japan Germany France
10Y 5Y
2020 Jun 2019 Jun
Source: Ping An Health. PICC Health total reported revenue is 22.775bn, however 6.75 bn is considered business that is
comparable with PAH. The remainder is mostly government related administrative business
55%
74%
590%
222%
0%
20%
40%
60%
80%
100%
120%
China US Germany UK
Individual Expenditure
Commercial Insurance
Social Medical Insurance

-- 79 of 84 --

80
Maintaining growth through distribution, the app and diversifying the
product offering
Distribution
Expanding distribution footprint*
Tier-2 branches
(provincial level)
of revenue online
(YTD)
Developing in full
swing in greater
Guangdong area
Expanding East
China market
steadily
Strong presence in
North China
Building
presence in
Southwest
*Only Mainland China depicted
Tier-3 branches
(city level)
NEW
20YR MEDICAL
REIMBURSEMENT PRODUCT
WITH DYNAMIC PRICING
Complete annual
health declaration
Submit verified
health data
Ongoing
physical activity
Score gives
health status
Premium discount
based on status
1
2
3
5 4
Online sales capability
Number of app users (m)
0
5
10
15
20
25
30
35
Millions

-- 80 of 84 --

81
Excellent results from Ping An Run Vitality
Improved up-selling Lower surrender rates Lower medical costs	Largest Vitality programme
Additional policies Lower surrenders Lower cost per event
2018 2019 2020
Members, 4 years since
inception 6m
5m
3m
RUN not
activated
RUN activated RUN not
activated
RUN
activated
Inactive Highly
active
RUN not
activated
RUN
activated
Inactive Highly
active
-59% -10%	+26% -23% -6%
Ping An Run Vitality is offered to all Ping An Fu policyholders purchasing after September 2016. Ping An Fu is Ping An Life’s flagship critical illness product Based on Ping An Life’s JianXiang and Zhuyuan rider
products, which cover hospital-related expenses

-- 81 of 84 --

82
Synergistic opportunities from the Ping An Health Ecosystem
Ping An Group is building a comprehensive ecosystem
-
200
400
600
800
1,000
1,200
Public Private
Revenue for healthcare services in China
(US$bn)
Source: NHFPC company analysis
Ping An Group seeks to capture the
rapid growth expected from the
Chinese private healthcare market
Private market worth
cUSD200bn
Patient
Provider
Payer
Ping An Technology
Ping An Health
Konnect
Ping An Smart City
Ping An Good Doctor
Ping An Shionogi
Co
Largest online healthcare
services platform
Administers managed healthcare platforms
for government-funded Social Health
Insurance funds
B2B digital services (AI, cloud computing,
blockchain, big data)
Joint venture building a data-driven
drug development platform, using
AI technology
346m Registered users
1st Global leader in fintech
patent applications
Cities in China
>800m 200
People
Uses of
AskBob bot
17k+ 22m
Medical
institutions
825m Online consultations
Smart integrated platform for medical
regulators and medical service providers
Source: Ping An Group 2020 Interim Results report
Specialist health insurer

-- 82 of 84 --

83
Perfect composite model, #1 in every industry, and laboratory for shared value in financial
services. A successful entry into banking
The best insurer in the UK, making use of a composite Shared-Value Model
Vitality is the world’s largest and most sophisticated behavioural platform linked to
financial services, with disciplined execution
Ping An Health delivers on its plan to become the leading health insurer in China with
over 50m clients
Focused on capital strength and liquidity
Operating performance was resilient
Interest rate movements impacted headline earnings
COVID-19 reserve to cater for all future COVID-19 impacts
Growth engine remains robust

-- 83 of 84 --

84
84
for the year ended 30 June 2020

-- 84 of 84 --